← All stocks

Aurinia Pharmaceuticals Inc.

AUPH Net buying

CIK 0001600620 #1941 in the set updated 17 Sep 2026

Bought (12 mo)

$25.14M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$546.37K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$546.37K

2 of 2 sales

Net

+$24.60M

+$24.60M against sales at will

By person

13 insiders · 13 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

TANG KEVIN

Chief Executive Officer

$25.14M (11)

—

+$25.14M

13,044,106

9.80%

$208.05M

+80.4%

Robertson Stephen P.

Chief Legal Officer

—

$546.37K (2)

−$546.37K

588,848

0.4426%

$9.39M

+32.0%

Greenleaf Peter

Chief Executive Officer

—

1,840,379

1.38%

$29.35M

+20.4%

Donley Matthew Maxwell

Chief Operating Officer

—

680,299

0.5113%

$10.85M

+15.1%

Miller Joseph M

Chief Financial Officer

—

576,421

0.4332%

$9.19M

+14.8%

Keenan Greg

SVP, Chief Medical Officer

—

154,449

0.1161%

$2.46M

+38.6%

Hearne Michael S

Chief Financial Officer

—

116,144

0.0873%

$1.85M

—

Cole Ryan

Chief Operating Officer

—

116,144

0.0873%

$1.85M

—

Jayne David R.W.

Director

—

56,499

0.0425%

$901.16K

+27.4%

Leversage Jill

Director

—

25,053

0.0188%

$399.60K

+93.9%

Smith Karen L.

Director

—

24,807

0.0186%

$395.67K

—

Bailey Jeffrey Allen

Director

—

22,775

0.0171%

$363.26K

—

Johnson Craig A

Director

—

14,592

0.0110%

$232.74K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 28

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 2

Transactions with no price 0

Shares from compensation/vesting 1,757,142

History held since 29 Jan 2021